ClinicalTrials.gg

Drug class

Cyclooxygenase Inhibitors clinical trials

A class of medicines: the studies that test any of its 55 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
2,871
open now
296
in phase 3
601
first study started
1990

Keep track of what changes. Save the cyclooxygenase inhibitors studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Aspirin, Dipyridamole Drug Combination
13

And 15 more, each tested in fewer studies.

Studies by the year they started

2,835 studies that test it; most in 2015 (150); 6 more planned to start later

Studies that test Cyclooxygenase Inhibitors, by start year
YearStudies
19901
19922
19936
19941
19962
19975
199810
199910
200027
200130
200267
200397
200484
200577
200695
200795
2008124
2009113
2010102
2011117
2012129
2013110
2014136
2015150
2016141
2017132
2018118
2019121
2020115
2021124
2022112
2023108
2024105
202599
202670

By phase

A phase 1/2 study counts in both.

Early Phase 1
98
Phase 1
447
Phase 2
685
Phase 3
601
Phase 4
738
No phase
462

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 718 · Other 2,153

Pfizer (52) · Bayer (45) · Boehringer Ingelheim (45) · Cairo University (44) · National Cancer Institute (NCI) (38) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (32) · Biogen (29) · M.D. Anderson Cancer Center (25)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 2,871

See all 2,871 studies that test one of the cyclooxygenase inhibitors →

Codes

What other systems call Cyclooxygenase Inhibitors · ClinicalTrials.gg INT008550

  • MeSH (NLM) D016861Cyclooxygenase InhibitorsOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.